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Most cases of candidosis have been attributed to Can-
dida albicans, but recently non-C. albicans Candida
species have been identified as frequent human patho-
gens. Candida pathogenicity has been attributed to
several factors, including adhesion to medical devices
and/or host cells, biofilm formation, and secretion of
hydrolytic enzymes (proteases, phospholipases and hae-
molysins). Although ‘new’ Candida species are emerg-
ing, there is still a lack of information about their
pathogenicity. This review discusses recent advances
in our knowledge of Candida glabrata, Candida para-
psilosis and Candida tropicalis virulence factors, specifi-
cally those of adhesion and biofilm formation, which are
key components in Candida pathogenicity.
Emergence of non-Candida albicans Candida species
Twenty years ago Candida albicans accounted for 70–80%
of the Candida isolates recovered from infected patients
[1]. Despite the majority of candidosis cases being attrib-
uted to C. albicans, an increasing number of infections
caused by non-C. albicans Candida (NCAC) species, spe-
cifically Candida glabrata, Candida parapsilosis and Can-
dida tropicalis, have been reported over the past two
decades [2–4].
For many years, C. glabrata was considered a relatively
non-pathogenic saprophyte of the normal flora of healthy
humans, and was not readily associated with serious in-
fection. However, C. glabrata can rapidly disseminate
throughout the body, and infection with this species is
associated with a high mortality rate. Moreover, C. glab-
rata is of added concern because of its inherent resistance
to certain antifungal agents [1].C. parapsilosis is generally
regarded as one of the least virulent yeast species, al-
though it is now a frequent cause of candidaemia, com-
monly related to poor hand hygiene of healthcare workers
[2]. C. tropicalis has emerged as the second or third most
common agent of candidaemia, mainly in oncology
patients, and is often associated with nosocomial uri-
nary-tract infections [4].
The apparently increasing involvement of NCAC spe-
cies in human candidosis could be related in part to
improvements in diagnostic methods, such as the use of
primary agars with the ability to differentiate between
Candida species, and the introduction of molecular diag-
nostic techniques into routine use [5]. A number of other
factors have been implicated in the increasing prevalence
of Candida species, including the introduction and more
widespread use of certain medical practices, such as im-
munosuppressive therapy, the use of broad-spectrum anti-
biotics, and an increase in the number of invasive surgical
procedures, such as organ transplantations [6,7]. Further-
more, the increasing number of Candida species in candi-
dosis could also be a reflection of species selection in the
presence of certain antifungals, given the higher level of
resistance demonstrated by several NCAC species [8].
The pathogenesis of invasive candidosis is facilitated by
a number of factors, including the ability to adhere to
medical devices and/or host cells and to form biofilms. It
is also important to highlight the ability of some Candida
species to switch from yeast to filamentous growth forms,
with the latter thought to increase the ability of the
organism to invade host tissues. C. albicans is a true
polymorphic organism, able to grow as hyphae and/or
pseudohyphae, and as blastospores (yeast). C. tropicalis
produces oval blastospores and pseudohyphae, and,
according to some reports, true hyphae. In the case of C.
parapsilosis, blastospore growth is prevalent, and al-
though this species does not produce true hyphae, it can
on occasion generate pseudohyphae. By contrast, C. glab-
rata is not polymorphic, growing only as blastospores [9].
Despite significant research aimed at identifying the
pathogenic factors of fungi, particularly in C. albicans,
relatively little is known about the virulence determinants
of NCAC species. This review aims to provide a contempo-
rary overview of the virulence factors associated with three
of these clinically important NCAC species (C. glabrata, C.
parapsilosis and C. tropicalis), with particular focus given
to aspects of their adhesion and biofilm formation.
Adhesion ability of NCAC species
The first event in Candida infection is its adherence of the
organism to host and/or medical-device surfaces, often
leading to the formation of biofilms [10]. Thus, adhesion
is an extremely important step in the infection process, and
the extent of adhesion is dependent on microbial, host and
abiotic surface properties, such as cell-surface hydropho-
bicity and cell-wall composition [11,12].
The yeast cell wall is the site for physicochemical inter-
actions between the microorganism and host surfaces,
leading to its adherence. The cell surface of C. glabrata
reportedly exhibits a degree of hydrophobicity comparable
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with that of C. albicans; however, these results were
obtained in a study of a limited number of C. glabrata
strains [13]. Interestingly, whereas the hydrophobicity of
C. albicans appears to be extremely sensitive to specific
growth conditions, the cell-surface hydrophobicity of nu-
merous isolates of C. glabrata was found to be compara-
tively stable under those same growth conditions [14]. In
addition, Camacho et al. [15] did not find a correlation
between the level of hydrophobicity and adherence of C.
albicans, C. tropicalis and C. parapsilosis to siliconized
latex catheters, demonstrating that cell hydrophobicity
alone was not a predictor of adhesion. However, Panagoda
et al. [16] demonstrated that the initial adhesion of C.
parapsilosis was associated with the hydrophobicity of
acrylic surfaces. Recently Silva et al. [17] showed that C.
glabrata adhered to silicone in the presence of urine at
higher levels than did either C. tropicalis or C. parapsi-
losis. Additionally, C. glabrata has also been reported to
have a two-fold greater tendency to adhere to denture-
acrylic surfaces compared with C. albicans [18]. Further-
more, C. glabrata has been shown to have higher adher-
ence to urinary epithelial cells than do other NCAC species
[19]. C. tropicalis has the ability to colonize urinary epi-
thelial cells [20]; however, the extent of adhesion is strain-
dependent. In terms of epithelial and endothelial adhesion
ability, few studies have been undertaken with C. para-
psilosis.
An important factor that has correlated with the adhe-
sion ability of Candida species is the presence of specific
cell-wall proteins, often referred to as adhesins. Groot et al.
[21] identified 23 C. glabrata cell-wall adhesins, which
were deemed to be involved in adherence to human epi-
thelia and in biofilm formation. A major group of adhesins
of C. glabrata is encoded by the EPA gene family [21–23].
The ability of C. glabrata to adhere to different bio-
materials and epithelia could be a reflection of epithelial
adhesin (EPA) expression on the surface of cells, which is
induced by the presence of nicotinic acid [24]. Although
there are relatively few studies concerningC. glabrataEpa
adhesins, it is known that Epa1p is a Ca2+-dependent
lectin [25]. Furthermore, despite the large number of
EPA genes, it has been shown that deletion of EPA1 alone
reduces adherence in vitro [25]. Furthermore, although
EPA6 is not expressed in vitro, its expression increases
during in vivo urinary infection, suggesting that C. glab-
rata can adapt with environmental conditions to enhance
its adherence [26]. A bioinformatics search of pathogen-
specific gene families of Candida species revealed a num-
ber of genes encoding cell-wall proteins in C. parapsilosis.
This study included five genes for agglutinin-like sequence
(ALS) proteins and six genes for predicted glycophospha-
tidylinositol-anchored protein 30 (Pga30) [27]. Unfortu-
nately, there has been no further work in studying the
role played by these proteins in C. parapsilosis adhesion.
Concerning proteins of the C. tropicalis cell wall, at least
three ALS-encoding genes have been identified [28], but to
our knowledge, no further work has been undertaken in
this area.
The pathogenesis of mucosal candidosis has mainly
been investigated using animal models, but recently,
reconstituted human epithelium (RHE) was successfully
used to study in vitro invasion by Candida species. In this
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Figure 1. Confocal laser scanning microscopy images and scheme of Candida species infecting of a reconstituted human oral epithelium after 12 h of colonization. Candida
yeast and filaments are shown in red, and the nucleic of the epithelial cells are depicted in blue. (a) C. parapsilosis showing moderate colonization, and invasion; (b) C.
tropicalis showing extensive colonization and invasion; (c) C. glabrata showing colonization but no invasion. *Yeast; ** filamentous forms.
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model, C. parapsilosis exhibited a high ability to colonize
the RHE, despite a lower ability to invade this tissue
[29,30] (Figure 1a). Furthermore, Ga´cser et al. [31] showed
that C. orthopsilosis caused similar damage to RHE,
whereas C. metaparapsilosis had comparatively reduced
virulence. Jayatilake et al. [32] showed increased ability of
C. tropicalis (Figure 1b) to colonize and invade RHE,
similarly to C. albicans, compared with C. glabrata
(Figure 1c) and C. parapsilosis (Figure 1b). C. glabrata
was shown to be non-invasive in this model [32]. Therefore,
given the inability of C. glabrata to generate filamentous
forms, it might be concluded that the filamentous form is
important for host tissue invasion.
Hydrolytic enzyme secretion by NCAC species
Candida species are able to produce and secrete several
hydrolytic enzymes, including proteases, phospholipases
(PLs) and haemolysins. The activity of these enzymes has
been associated with candidal adhesion, cell damage and
invasion of host tissue.
Secreted aspartyl proteinases
The secretion of aspartyl proteinases (Sap1 to Sap10) by C.
albicans is recognized as an important virulence determi-
nant for this species [33]. Saps facilitate colonization and
invasion of host tissues through the disruption of host
mucosal membranes [34], and by degrading important
immunological and structural defence proteins [35].
With regard toC.glabrata, only one studyhas shown that
this species is capable of secreted proteinase production, but
the type of proteinase was not specified [36]. In addition,
compared with C. albicans, C. parapsilosis has been shown
to possess relatively low Sap activity [37]. Only three SAP
geneshavebeen identified inC.parapsilosis (SAPP1–3), two
of which remain largely uncharacterized [38]. It has been
reported that the expression of SAPP1–3 genes varies with
the clinical isolate of C. parapsilosiswhen grown in contact
with an oral epithelium and even in planktonic form [30].
However, an associated trend was also reported, which
related Sap production and the site of isolation of the
organism; both vaginal and skin isolates of C. parapsilosis
exhibited higher in vitro Sap activity than blood isolates
[39].C. parapsilosis poorly invades oral epithelium, but can
nevertheless induce significant damage, which was related
to specific SAP gene expression [30].
As with C. albicans, in vitro studies revealed that C.
tropicalis secretes high levels of Saps in culture media
containing bovine serum albumin as the sole source of
nitrogen. Furthermore, C. tropicalis possesses at least four
genes encoding Saps (SAPT1–4) [40,41], although Sapt1p
is the only one that has been purified from culture super-
natant, and biochemically characterized and crystallized
[42,43]. Sap secretion by C. tropicalis has also been
reported on the surface of fungal elements penetrating
tissues during disseminated infection, and on macro-
phages following phagocytosis of yeast cells [34]. Sap ex-
pression by C. tropicalis in the oral environment is not
associated with invasion or tissue damage [44], a finding
similar to that reported for C. albicans [45,46].
Despite the high number of studies concerning the role
of Saps on C. albicans virulence, little emphasis has been
given to NCAC species Saps. Moreover it is important to
highlight that although several studies have highlighted
the differential expression and potential roles of various
SAP genes during colonization and infection of host by
Candida species, there were discrepancies in the results
obtained. The reasons for such discrepancies could relate to
differences in the sensitivities of the methods used, intrin-
sic differences even in apparently similar infection models
(e.g. RHE and murine), and interspecies and strain vari-
ability [45,47].
PLs and lipases
In addition to Saps, enzymes categorized as lipases and
PLs are often considered to be factors associated with
Candida pathogenicity.
PLs are enzymes that hydrolyze phospholipids to fatty
acids. Depending on the different and specific ester bonds
cleaved, these enzymes have been classified into PLs A, B,
C and D [48]. The production of all classes of PLs has been
described for Candida species, and their presence could
conceivably contribute to host cell-membrane damage,
which could promote cell damage and/or expose receptors
to facilitate adherence of Candida [49].
Several studies have indicated that NCAC species are
able to produce extracellular PLs [50,51], albeit at lower
levels compared with C. albicans [45]. There have been a
number of contradictory findings, with some investigators
reporting PL activity in 51% of strains assayed, whereas
others have failed to detect PL activity in assayed strains
[45]. Although C. tropicalis appears to have a reduced
ability to produce extracellular PLs, this is strongly
strain-dependent [21,38,52,53]. Furthermore, although a
few studies of PL activity have been undertaken for C.
tropicalis and C. parapsilosis, none has been reported for
C. glabrata [54].
Lipases are involved both in the hydrolysis and synthe-
sis of triacylglycerols. These enzymes are stable at high
temperatures and in organic solvents and are resistant to
proteolysis. In C. albicans, 10 lipase genes have been
identified [55]. Ga´cser et al. [56] showed that C. albicans
mutants deficient in CaLIP8 were significantly less viru-
lent in a murine intravenous infection model. This work
clearly indicated that Lip8p was likely to be an important
virulence factor for this particular species. For C. para-
psilosis, CpLIP1 and CpLIP2 have been reported, with the
latter known to encode for an active protein [57,58]. Re-
cently, Ga´cser et al. [31] demonstrated that a lipase inhibi-
tor significantly reduced tissue damage during C.
parapsilosis infection of reconstituted human tissues,
and thatCpLIP1/CpLIP2mutants formed thinner and less
complex biofilms. Recent genomic DNA sequencing sug-
gests that two additional CpLIP genes might exist in C.
parapsilosis [2]. Sequences similar to C. albicans (LIP1–
10) were also detected in C. tropicalis, but not in C.
glabrata [59]. However, no studies have been performed
to investigate the role of these genes in the virulence of C.
tropicalis.
Haemolytic activity
Pathogenic microorganisms can grow in the host by using
haemin or haemoglobin as a source of iron. Haemolysins
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are produced by Candida species to degrade haemoglobin
and extract elemental iron from host cells. Thus, haemo-
lysins are likely to be key virulence factors as might
promote pathogen survival and persistence in the host
[60,61]. C. albicans has the ability to further utilize the
acquired iron to produce a haemolytic factor that can
release more haemoglobin by lysing erythrocytes [60,61].
Candida haemolytic activity can be concentrated by ab-
sorption on a concanavalin-A sepharosematrix. Analysis of
the absorbed haemolysin demonstrated that the haemoly-
tic factor involved was mannoprotein in origin [61]. Pro-
duction of this haemolysin appears to be regulated by the
presence of glucose in the growth medium. C. glabrata, C.
parapsilosis and C. tropicalis are also able to produce
haemolysins in vitro and at various levels, inducing partial
or total erythrocyte lysis [59]. The genetic expression of
haemolytic activity by Candida is, at present, poorly un-
derstood, but Luo et al. [62] showed that the haemolysin-
like protein (HLP) gene was associated with the hemolytic
activity of C. glabrata. Clearly, investigations are at an
early stage with respect to the haemolysin activity of
Candida species. This is highlighted by the fact that for
pathogenic fungi, cloning, disruption and virulence evalu-
ation has only led to the identification of the C. albicans
haemolysin. Further investigations aimed at determining
the role of haemolysins in the virulence of different NCAC
species are required to establish whether these molecules
are universal virulence factors of Candida species.
Apart from C. albicans, our knowledge of fungal adhe-
sion, colonization and invasion of human epithelia and
medical devices remains limited. The first contact between
microorganisms and host surfaces is generally via the
fungal cell wall, and this is therefore believed to play a
key role in the pathogenicity ofCandida species. Therefore,
elucidation of the physicochemical properties (e.g. hydro-
phobicity), including chemical composition, should facili-
tate better understanding of the pathogenesis of NCAC
infections. Furthermore, establishing the role of cell-wall
components in the infection process could also enhance
management strategies by potentially identifying appro-
priate and alternative targets for antifungal drugs.
Biofilm formation by NCAC species
Initial attachment of Candida to the host or/and medical
devices is followed by cell division, proliferation and sub-
sequent biofilm development [63]. Biofilms are surface-
associated communities of microorganisms embedded
within an extracellular matrix (ECM), and are considered
the most prevalent growth form of microorganisms [64].
Biofilm formation is a potent virulence factor for a number
of Candida species, as it confers significant tolerance to
antifungal therapy, primarily by limiting the penetration
of substances through the biofilm matrix. Growth as a
biofilm also serves to protect the embedded cells from host
immune responses [65]. Moreover, C. albicans, C. para-
psilosis, C. tropicalis and C. glabrata isolates are adept at
forming biofilms, and their presence during infection has
been linked to higher mortality rates compared with iso-
lates incapable of forming biofilms [66]. It is thought that
the formation of mature biofilms and subsequent produc-
tion of the ECM is strongly dependent upon species, strain,
and environmental conditions such as pH, medium compo-
sition and oxygen [63,67].
Table 1 summarizes the most relevant characteristics of
C. parapsilosis, C. tropicalis and C. glabrata biofilms. C.
albicans biofilm formation is associated with the dimorphic
switch between yeast and hyphal growth, and biofilms of
this species generally have two distinct layers: a thin, basal
yeast layer and a thicker, less compact hyphal layer [68]. In
contrast to C. albicans, C. parapsilosis biofilms (Figure 2)
tend to be thinner, less structured, and consist almost
exclusively of aggregated blastospores [69]. Interestingly,
biofilm formation by C. parapsilosis is strongly strain-
dependent [64]. The selective preference of this species
for plastic medical devices is of particular interest, as
biofilm formation enhances the capacity of C. parapsilosis
Table 1. C. tropicalis, C. parapsilosis and C. glabrata biofilm characteristics
Species Biofilm formationa Matrix composition Biofilm structure
C. tropicalis + Low level of carbohydrates and proteins Discontinuous compact monolayer
C. parapsilosis + High level of carbohydrates and low levels of proteins Discontinuous monolayer or multilayer
C. glabrata +/! High level of carbohydrates and proteins Compact monolayer or multilayer
a+, Robust biofilm growth; +/!, less biofilm growth.
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Figure 2. Biofilm structure of C. glabrata, C. parapsilosis and C. tropicalis. Scanning electron microscopy images taken after biofilm growth in SDB after 48 h.
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to colonize catheters and intravascular central lines [2]. C.
tropicalis clinical isolates have been classified as being
prolific biofilm formers [21,64], and their mature biofilms
consist of a dense network of yeast cells in addition to
evident filamentousmorphologies (Figure 2) [64]. A genetic
screen of C. glabrata biofilm mutants identified four genes
involved in biofilm formation, and biofilm growth condi-
tions induced the transcription of EPA6 and EPA7 [70]. C.
glabrata biofilms exhibit a more compact structure than
those of C. tropicalis and C. parapsilosis biofilms
(Figure 2). Additionally, two newly identified Candida
species (C. orthopsilosis and C. metapsilosis) have also
been shown to be capable of forming biofilms [71]. It must
be stressed that comparisons of the biofilms formed by C.
glabrata, C. tropicalis and C. parapsilosis should always
consider the inherent physiological differences between
these species, such as relative cell size, morphology and
biochemistry. When comparing Candida biofilms, future
research should carefully define the most appropriate
parameters to investigate.
Biofilm formation and matrix composition are strongly
dependent on the strain and the environmental conditions
(medium composition, pH and oxygen) used [63]. Recently,
Silva et al. [17] showed that C. glabrata produced higher
biofilm biomass on silicone in the presence of urine, com-
pared withC. parapsilosis and C. tropicalis. Conversely, C.
tropicalis and C. parapsilosis yielded a higher biofilm
biomass in Sabouraud dextrose broth (SDB) compared
with C. glabrata [64]. These results are in accordance with
Shin et al. [72], who reported that biofilm formation by C.
glabrata was lower than that of other NCAC species, when
cultured in nutritionally rich media. C. glabrata cells are
smaller (1–4 mm) than those of C. tropicalis (4–8 mm) and
C. parapsilosis (2.5–4 mm) and also have a narrower spec-
trum of carbohydrate utilization. Unlike C. parapsilosis
and C. tropicalis, C. glabrata is unable to generate fila-
mentous forms, which might also be expected to exhibit
different metabolic activities, and thus this might contrib-
ute to the lower amount of C. glabrata biomass in rich
medium. Such factors undoubtedly reflect the inherent
physiological differences between these species, and could
have significance for their pathogenic potential. Biofilms
are readily formed by C. parapsilosis cells grown in media
containing high glucose and lipid concentrations, which
can be thought of being analogous to bloodstream infec-
tions in patients receiving parenteral nutrition. These
results highlight the observation that biofilm formation
and consequent matrix production are strongly dependent
on the source of nutrients available.
The biofilm matrix of C. albicans is mainly composed of
carbohydrates, proteins, phosphorus and hexosamines [73].
Thematrix ofC.glabratabiofilmsproduced inSDBhasbeen
found to contain high levels of proteins and carbohydrates
[64]. The ECM of C. parapsilosis biofilms is composed of
large quantities of carbohydrates, and the protein content is
low compared with biofilms of C. glabrata and C. tropicalis
[64]. The matrix of C. tropicalis biofilms also has a notable
difference from those of the other NCAC species. Although
the C. tropicalis matrix contains carbohydrates, proteins,
hexosamine, phosphorus and uronic acid [74], it has lower
amounts of carbohydrates and protein [64]. Furthermore,
the major component in the C. tropicalis biofilm matrix is
hexosamine (27%). In addition, C. tropicalis biofilms can be
partially detached after treatment with lipase type VII and
chitinase, whereas biofilms of C. albicans are detachable
after treatment with proteinase K, chitinase, DNase I or b-
N-acetylglucosamidase [74]. These findings highlight that
detachment and destruction of NCAC biofilms is dependent
onmatrix composition. This opens the possibility that some
medical devices could be coated with specific types of hydro-
lytic enzymes as ameans of preventing biofilm formation by
NCAC species.
Several genes and proteins have been reported as es-
sential for Candida biofilm formation and matrix compo-
sition. Two recent studies showed that C. parapsilosis LIP
knockout mutants had a decreased ability to form biofilms.
C. parapsilosis lipase mutants produce significantly less
biofilm than wild-type strains [31], and the biofilm and cell
wall regulator (BCR) gene was found to be necessary for
proper biofilm formation [75]. Notably, the biofilm-defi-
cient C. parapsilosis lipase mutants were less virulent in
tissue culture infection models and also in mice [31]. Little
is known about the genes involved in biofilm formation for
C. glabrata and C. tropicalis.
The studies described above highlight the diversity
found for C. glabrata, C. parapsilosis and C. tropicalis,
in terms of biofilm-forming ability, structure and matrix
composition. It must be emphasized that it is clearly very
important to continue these studies to elucidate the inher-
ent differences between these and other NCAC species to
identify and combat their involvement in infection.
Concluding remarks
An alteration to host immunity is generally required by
opportunistic pathogens, such as Candida, to switch from
harmless commensal microorganisms to potentially life-
threatening human pathogens. Candida utilizes several
genes, which play an important role in adhesion, biofilm
formation and secretion of enzymes, and are consequently
involved in virulence. Given these findings and the in-
creased incidence of candidosis caused by NCAC species,
especially C. glabrata, C. parapsilosis and C. tropicalis,
and the unacceptably high morbidity and mortality asso-
ciated with them, it is essential to increase our knowledge
about the factors associated with adhesion and biofilm
formation in NCAC infections. Further studies in this area
will also contribute towards the identification of new tar-
gets for future therapeutics against these recently emerged
pathogens (Box 1).
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